In gastric cancer, tanshinone I suppresses cisplatin-resistant cell growth by activating the NF-κB/caspase-3/8/GSDME signaling pathway and stimulating pyroptosis (Wang G. et al., 2024). The gene discussed is GSDME; the disease is gastric cancer.